个人信息
教师姓名:肖德胜

学位:博士学位

学历:研究生(博士)毕业

职称:教授

所在单位:湘雅基础医学院

学术荣誉: 曾获荣誉:
个人简介

    中南大学教授,博士生/博士后导师,现任中南大学基础医学院病理学系/湘雅医院病理科副主任、分子病理诊断中心主任。病理学国家级精品课程主讲教师、病理学国家级资源共享课程主讲教师及基础医学形态学国家级教学团队、卫计委临床重点专科骨干成员,副主编及参编《病理学》全国高等学校医学规划教材及配套教材15本,人民卫生出版社国家医学教育题库病理学学科副主编,获校级教学成果奖8项;参编专家共识2项。主持国家自然科学基金及省厅级项目10余项,作为子课题负责人参与湖南省重点研发计划项目一项,获湖南省医学学科C类项目一项(200万元)。近5年以通讯作者在PNAS、Cancer Research、Cell Discovery、Nucleic Acids Res、Signal Transduct Target Ther 、Molecular Cancer 、Advanced Science 等国际知名期刊发表论文61篇。获湖南医学科技奖一等奖一项、中华医学科技奖二等奖一项、中国抗癌协会科技奖二等奖一项。获湘雅医院医疗技术成果奖三等奖一项。湘雅医院十佳医师。

Desheng Xiao, Ph.D., professor, PhD candidate/post-doctoral supervisor, Deputy Director of Department of Pathology, Basic Medical School/Xiangya Hospital, Central South University, Director of Molecular Pathology Diagnosis Center.  Main lecturer of the National Excellent Course of Pathology and the National Resource Sharing Course of Pathology, and a key member of the National Teaching Team of Basic Medical Morphology and the Key Clinical Specialty of the National Health and Family Planning Commission. Co-editor and contributor to 15 national medical planning textbooks and supplementary materials of "Pathology" published by People's Medical Publishing House, and deputy editor of the National Medical Education Question Bank of Pathology. Won 8 teaching achievement awards at the university level. Participated in the compilation of 2 expert consensus. Has presided over more than 10 projects funded by the National Natural Science Foundation and provincial and ministerial-level departments, and served as the sub-project leader of one key research and development project of Hunan Province, and obtained one C-class project of Hunan Medical Science and Technology (2 million yuan). In the past five years, 61 papers have been published as the corresponding author in international renowned journals such as PNAS, Cancer Research, Cell Discovery, Nucleic Acids Res, Signal Transduct Target Ther, Molecular Cancer, and Advanced Science. Won one first prize of Hunan Medical Science and Technology Award, one second prize of Chinese Medical Science and Technology Award, and one second prize of China Anti-Cancer Association Science and Technology Award. Won one third prize of Xiangya Hospital Medical Technology Achievement Award. Xiangya Hospital's top ten physicians.



论文成果
当前位置 : 中文主页 >> 论文成果

The survival analysis and oncogenic effects of CFP1 and 14-3-3 expression on gastric cancer


点击次数:

影响因子:4.175

所属单位:中南大学

教研室:病理学系

发表刊物:Cancer Cell Int

关键字:14-3-3; CFP1; Gastric cancer

摘要:Background & aim: Gastric cancer (GC) is the third-leading cause of cancer-related deaths. We established a prospective database of patients with GC who underwent surgical treatment. In this study, we explored the prognostic significance of the expression of CFP1 and 14-3-3 in gastric cancer, by studying the specimens collected from clinical subjects. Materials & methods: Immunohistochemistry was used to detect the expression of CFP1 and 14-3-3 in 84 GC subjects, including 73 patients who have undergone radical gastrectomy and 11 patients who have not undergone radical surgery. Survival analysis was performed by km-plot data. Results: According to the survival analysis, we can see that the survival time of patients with high expression of CFP1 is lower than the patients with low expression in gastric cancer, while the effect of 14-3-3 is just the opposite. The survival time of patients with higher expression of 14-3-3 is also longer. Conclusion: The CFP1 and 14-3-3 genes can be used as prognostic markers in patients with GC, but the study is still needed to confirm.

合写作者:Yao Long, Xin Peng, Desheng Xiao, Jianhua Zhou, Yongguang Tao

第一作者:Jingyue Sun

论文类型:期刊论文

通讯作者:Shuang Liu

期号:19

页面范围:225

是否译文:

发表时间:2019-08-31

收录刊物:SCI


上一条: DNA methylation modifier LSH inhibits p53 ubiquitination and transactivates p53 to promote lipid metabolism

下一条: GIAT4RA functions as a tumor suppressor in non-small cell lung cancer by counteracting Uchl3-mediated deubiquitination of LSH


手机版

同专业博导  同专业硕导

访问量:

中南大学版权所有 湘ICP备05005659号-1

最后更新时间:..